The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells

Blood

Volumn 88, Issue 6, 1996, Pages 2298-2305

  Marathi, Upendra K ^b   Howell, Sherie R ^b   Ashmun, Richard A ^b   Brent, Thomas P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL GROWTH; CONTROLLED STUDY; DNA CROSS LINKING; DNA DEGRADATION; DNA DETERMINATION; FANCONI ANEMIA; GENE EXPRESSION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; LYMPHOBLAST; PRIORITY JOURNAL;

EID: 0029847786     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2298.bloodjournal8862298     Document Type: Article

References (52)

1. Schroeder TM, Tilgen D, Kruger J, Vogel J: Formal genetics of Fanconi's anemia. Hum Genet 32:257, 1976
2. Schroeder TM, Anschutz F, Knoop A: Spontane chromosomen-aberrationen bei familiarer panmyelopathie. Humangenetik 1:194, 1964
3. Fanconi G: Familiare, infantile perniziosaartige anämie (pernizioses blutbild und Konstitution). Z Kinderheilkude 117:257, 1927
4. Auerbach AD, Rogatko A, Schroeder-Kruth TM: International Fanconi Anemia Registry: Relation of clinical symptoms to diepoxybutane sensitivity. Blood 73:391, 1989
5. Swift M: Fanconi's anaemia in the genetics of neoplasia. Nature 230:270, 1971
6. Ebell W, Friedrich W, Kohne E: Therapeutic aspects of Fanconi anemia, in Auerbach AD, Obe G (eds): Fanconi Anemia: Clinical, Cytogenetic, and Experimental Aspects. Berlin, Germany, Springer-Verlag, 1989, p 27
7. Sasaki MS, Tonomura A: A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 33:1829, 1973
8. Ishida R. Buchwald M: Susceptibility of Fanconi's anemia lymphoblasts Io DNA-cross-linking and alkylating agents. Cancer Res 42:4000, 1982
9. Fujiwara Y, Kano Y, Yamamoto Y: DNA interstrand cross-linking, repair, and SCE mechanism in human cells in special reference to Fanconi anemia. Basic Life Sci 29:787, 1984
10. Auerbach AD: Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 21:731, 1993
11. Cervenka J, Arthur D, Yasis C: Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia. Pediatrics 67:119, 1981
12. Colvin M: The alkylating agents, in Chabner B (ed): Pharmacologic principles of Cancer Treatment. Philadelphia, PA, Saunders, 1982,p 276
13. Price CC, Gaucher GM, Konesa P, Shibakawa R, Sowa JR, Yamaguchi M: Relative reactivities of monofunctional nitrogen mustard alkylation of nucleic acid components. Biochim Biophys Acta 166:327, 1968
14. Mehta JR, Przbylski M, Ludlam DB: Alkylation of guanosine and deoxyguanosine by phosphoramide mustard. Cancer Res 40:4183, 1980
15. Brooks P, Lawley PD: The reaction of mono- and difunctional alkylating agents with nucleic acids. Biochem J 80:496, 1961
16. Kohn KW, Spears CL, Doty P: Inter-strand crosslinking of DNA by nitrogen mustard. J Mol Biol 19:266, 1966
17. Erickson LC, Rumonas LM, Zaharko DS, Kohn KW: Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Cancer Res 40:4216, 1980
18. Ewing RAG, Kohn KW: DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chlo-roethy1)-]-nitrosourea, and other nitosoureas. Cancer Res 38:2114, 1977
19. Zwelling LA, Michaels S, Schwartz H, Dobson PP, Kohn KW: DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diaminedichloroplatinum (II) and L-phenylalanine mustard. Cancer Res 41:640, 1981
20. O'Connor PM, Kohn KW: Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards. Cancer Commun 2:387, 1990
21. Tokuda K, Bodell WJ: Cytotoxicity and sister chromatid exchanges in 9L cells treated with monofunctional and bifunctional nitrogen mustards. Carcinogenesis 8:1697, 1987
22. Doskocil J, Sormova Z: The reaction of mustards. I. The reaction products. Collect Czech Chem Commun 30:481, 1965
23. Osborne MR, Wilman DEV, Lawley PD: Alkylation of DNA by nitrogen mustard bis (2-chloroethyl) methylamine. Chem Res Toxicol 8:316, 1995
24. Pieper RO, Futscher BW, Erickson, LC. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro. Carcinogenesis 10:1307, 1989
25. O'Connor PM, Wassermann K, Sarang M, Magrath I, Bohr VA, Kohn KW: Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard. Cancer Res 51:6550, 1991
26. Auerbeck D, Papadopoulo D, Moustacchi E: Repair of 4,5′,8-trimethylpsoralen plus light-induced DNA damage in normal and Fanconi's anemia cell lines. Cancer Res 34:230, 1988
27. Cohen MM, Fruchtman CE, Simpson SJ, Martin AO: The cytogenetic response of Fanconi's anemia lymphoblastoid cell lines to various clastogens. Cytogenet Cell Genet 34:230, 1982
28. Fornace AJ, Little LB, Weichselbaum RR: DNA repair in a Fanconi's anemia fibroblast cell strain. Biochim Biophys Acta 561:99, 1979
29. Kaye J, Smith C, Hanawalt PC: DNA repair in human cells containing photoadducts of 8-methyoxypsoralen or angelicin. Cancer Res 40:696, 1980
30. Poll EH, Arwert F, Kortbeek HT, Eriksson AW: Fanconi anemia cells are not uniformly deficient in unhooking of DNA interstrand crosslinks induced by mitomycin C or 8-methoxypsoralen plus UVA. Hum Genet 68:228, 1984
31. Rey JP, Scott R, Muller HJ: Induction and removal of interstrand crosslinks in the ribosomal RNA genes of lymphoblastoid cell lines from patients with Fanconi anemia. Mutat Res 289:171, 1993
32. Fujiwara Y: Defective repair of mitomycin C crosslinks in Fanconi's anemia and loss in confluent normal human and xeroderma pigmentosum cells. Biochim Biophys Acta 699:217, 1982
33. Fujiwara Y, Tatsumi M, Sasaki MS: Cross-link repair in human cells and its possible defect in Fanconi's anaemia cells. J Mol Biol 113:635, 1977
34. Gruenert DC, Cleaver JE: Repair of psoralen-induced cross-links and monoadducts in normal and repair-deficient human fibroblasts. Cancer Res 45:5399, 1985
35. Strathdee CA, Duncan AMV, Buchwald M: Evidence for at least four Fanconi anemia genes including FACC on chromosome 9. Nature Genet 1:196, 1993
36. Joenje H, Lo Ten foe JR, Oostra AB, van Berkel CGM, Rooimans MA, Schroeder-Kruth T, Wegner RD, Gille JJP, Buchwald M, Arwert F: Classification of Fanconi anaemia patients by complementation analysis: Evidence for a fifth genetic subtype. Blood 86:2156, 1995
37. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356:763, 1992
38. Yamashita T, Barber DL, Zhu Y, Wu N. D'Andrea AD: The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 91:6712, 1994
39. Youssoufian H: Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 91:7975, 1994
40. Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young, NS, Liu JM: Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 94:1440, 1994
41. Segal GM, Magenis SRE, Brown M, Keeble W, Smith TD, Heinrich MC, Bagby GC: Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic cells. J Clin Invest 94:846, 1994
42. Bagby GC, Kenney N, Rathbun K, Keeble W, Tower P: The C-type Fanconi anemia complementing gene encodes a protein that slows the death rate of factor-deprived hematopoietic cells in vitro. Blood 84:14a, 1994 (abstr)
43. Sellins KS, Cohen JJ: Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139:3199, 1987
44. Kelly SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS: Overexpression of metallothionein confers resistance to anticancer drugs. Science 241:1813, 1988
45. Tew KD, Clapper ML: Glutathione S-transferases and anticancer drug resistance, in Wolley PW, Tew KD (eds): Mechanisms of Drug Resistance in Neoplastic Cells. San Diego, CA, Academic, 1988, p 141
46. Seyschab H, Bretzel G, Friedl R, Schindler D, Sun Y, Hoehn H: Modulation of the spontaneous G2 phase blockage in Fanconi anemia cells by caffeine: Differences from cells arrested by X-irradiation. Mutat Res 308:149, 1994
47. Kruyt FAE, Dijkmans LM, van der Berg TK, Joenje H: Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblast cell lines. Blood 87:938, 1996
48. Roberts JJ, Pascoe JM, Plant JE, Sturrock JE, Crathorn AR: Quantitative aspects of the repair of alkylated DNA in cultured mammalian cells. I. The effect on Hela and Chinese hamster cell survival of alkylation of cellular macromolecules. Chem Biol Interact 3:29, 1971
49. Matsumoto A, Vos JMH, Hanawalt PC: Repair analysis of mitomycin C-induced DNA crosslinking in ribosomal RNA genes in lymphoblastoid cells from Fanconi's anemia patients. Mutat Res 217:185, 1989
50. Walsh CE, Mann MM, Emmons RVB, Wang SH, Liu, JM: Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene. J Invest Med 43:379, 1995
51. Brent TP: Suppression of cross-link formation in chloroethylnitrosourea-treated DNA by an activity in extracts of human leukemic lymphoblasts. Cancer Res 44:1887, 1984
52. Futscher BW, Pieper RO, Dalton WS, Erickson LC: Genespecific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR. Cell Growth Differ 3:217, 1992